Diabetes Care, Vol 19, Issue 1 79-89, Copyright © 1996 by American Diabetes Association

ARTICLES

Microalbuminuria in patients with NIDDM: an overview

AA Alzaid
Department of Medicine, Riyadh Armed Forces Hospital, Saudi Arabia.

We have come a long way in our understanding of the epidemiology, pathophysiology, and clinical significance of albuminuria in patients with NIDDM. However, substantial gaps remain to be defined. NIDDM nephropathy is a serious and increasingly burdensome disease for both the diabetic individual and the society at large. Onset of microalbuminuria, an early but common manifestation of NIDDM nephropathy, marks an ominous turn for the NIDDM patient, in whom its development forecasts a grave cardiovascular outcome. Interception of albuminuria with antihypertensive agents such as ACE inhibitors in otherwise healthy NIDDM subjects holds a significant promise but must first await further investigation.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Uehara, H. Makino, K. Seiki, Y. Urade, and on behalf of L-PGDS Clinical Research Group of Kid Urinary excretions of lipocalin-type prostaglandin D synthase predict renal injury in type-2 diabetes: a cross-sectional and prospective multicentre study Nephrol. Dial. Transplant., September 17, 2008; (2008) gfn515v1. [Abstract] [Full Text] [PDF]

				H. Akahori, T. Ota, M. Torita, H. Ando, S. Kaneko, and T. Takamura Tranilast Prevents the Progression of Experimental Diabetic Nephropathy through Suppression of Enhanced Extracellular Matrix Gene Expression J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 514 - 521. [Abstract] [Full Text] [PDF]

				S.-M. Herrmann, J. Ringel, J.-G. Wang, J. A. Staessen, and E. Brand Peroxisome Proliferator-Activated Receptor-{gamma}2 Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study Diabetes, August 1, 2002; 51(8): 2653 - 2657. [Abstract] [Full Text] [PDF]

				J. P Garg and G. L Bakris Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease Vascular Medicine, February 1, 2002; 7(1): 35 - 43. [Abstract] [PDF]

				R. C.P. Go, R. Desmond, J. M. Roseman, D. S.H. Bell, C. Vanichanan, and R. T. Acton Prevalence and Risk Factors of Microalbuminuria in a Cohort of African-American Women With Gestational Diabetes Diabetes Care, October 1, 2001; 24(10): 1764 - 1769. [Abstract] [Full Text] [PDF]

				B. P. Tabaei, A. S. Al-Kassab, L. L. Ilag, C. M. Zawacki, and W. H. Herman Does Microalbuminuria Predict Diabetic Nephropathy? Diabetes Care, September 1, 2001; 24(9): 1560 - 1566. [Abstract] [Full Text] [PDF]

				M. Roest, J. D. Banga, W. M. T. Janssen, D. E. Grobbee, J. J. Sixma, P. E. de Jong, D. de Zeeuw, and Y. T. van der Schouw Excessive Urinary Albumin Levels Are Associated With Future Cardiovascular Mortality in Postmenopausal Women Circulation, June 26, 2001; 103(25): 3057 - 3061. [Abstract] [Full Text] [PDF]

				A Varghese, R Deepa, M Rema, and V Mohan Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India Postgrad. Med. J., June 1, 2001; 77(908): 399 - 402. [Abstract] [Full Text]

				C. T. Valmadrid, R. Klein, S. E. Moss, and B. E. K. Klein The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus Arch Intern Med, April 24, 2000; 160(8): 1093 - 1100. [Abstract] [Full Text] [PDF]

				R. Bilous Blood pressure control in type 2 diabeteswhat does the United Kingdom prospective diabetes study (UKPDS) tell us? Nephrol. Dial. Transplant., November 1, 1999; 14(11): 2562 - 2564. [Full Text] [PDF]